Scientific Projects
Scientific Projects
Project Area A: Synthesis, Drug Uptake, and Labelling | ||
|---|---|---|
| A01 | R. Bodmeier (Pharmaceutical Technology, Institute of Pharmacy, FU Berlin) | Development of "smartNLC" and "ARTcrystals" for dermal application of drugs |
| A02 | R. Haag (Institute of Chemistry and Biochemistry, FU Berlin) | Polymer architectures with responsive nanocarriers for drug delivery |
| A03 | A. Lendlein/A. Neffe (Inst. for Biomaterials Reserarch, Helmholtz Zentrum Geesthacht, Teltow) | Drug releasing, biodegradable depsipeptide nanoparticles for dermal treatments |
| A04 | R. Haag/M. Calderón (Institute of Chemistry and Biochemistry, FU Berlin) | Development of pH-cleavable and thermoresponsive nanogels as nanocarriers for the transdermal triggered release of drugs |
Project Area B: Physical Diagnostics and Numerical Models | ||
| B01 | M. Meinke/R. Bittl (Dermatology, Charité Berlin / (Department of Physics, FU Berlin) | EPR spectroscopic investigations on drug delivery and release of nanocarriers into cutaneous cells and excised skin |
| B02 | E. Rühl (Institute of Chemistry and Biochemistry, FU Berlin) | Spatially and temporally resolved studies on the transport of nanocarriers and drug release in cells and skin |
| B03 | U. Alexiev (Department of Physics, FU Berlin) | Characterization of transport and release properties of responsive nanocarriers by fluorescence spectroscopy and localization microscopy |
| B04 | R. Netz Department of Physics, FU Berlin) | Multiscale models for carrier-assisted drug transport through skin |
Project Area C: Nanopharmacology and Dermatology | ||
| C02 | M. Schäfer-Korting/S. Hedtrich, née Küchler (Institute of Pharmacy, FU Berlin) | In vitro disease models – test platform for the investigation of nanocarrier related transport, activity, and toxicity of drugs |
| C03 | L. Mundhenk/A. Gruber Department of Veterinary Medicine, FU Berlin) | Nanocarriers in the skin of mouse models: Penetration, effects of barrier dysfunctions in diseased skin and improved targeting of inflammation |
| C04 | A. Vogt/U. Blume-Peytavi (Dermatology, Charité Berlin) | Ex vivo human skin: Impact of skin barrier function and the presence of hair follicles on nanocarrier-based anti-inflammatory therapy |
| C05 | J. Lademann (Dermatology, Charité Berlin) | Dermal trigger parameters for drug release from nanocarriers |
Central Projects | ||
| Z01 | B. Kleuser/N. Ma/M. Schäfer-Korting (Institute of Nutrition Science, U Potsdam/Inst. for Biomaterials Research, Helmholtz Zentrum Geesthacht (Teltow)/ Institute of Pharmacy, FU Berlin) | Toxicity of native and drug-loaded nanocarriers |
| MGK | E. Rühl (Institute of Chemistry and Biochemistry, FU Berlin) | Integrated Research Training Group “Nanocarriers" |
| Z02 | E. Rühl /Institute of Chemistry and Biochemistry, FU Berlin) | Central tasks - CRC Headquarter and administration |